Скачать или смотреть FY2024 | Your Support and How it Was Used | Chiara Falcomatà, PhD, CRI Postdoctoral Fellow

Welcome back to the Cancer Research Institute's Fiscal Year 2024 Impact Video Series—your access to the forefront of cancer and immunotherapy research.

Our second video features CRI Postdoctoral Fellow Chiara Falcomatà, PhD, who is leading cutting-edge research aimed at uncovering how pancreatic cancer cells evade the immune system. By identifying critical signals within tumors and blood, Dr. Falcomatà is shedding light on pathways for earlier diagnosis and more effective treatments. Her groundbreaking work has the potential to revolutionize how we approach this challenging disease, offering new hope for life-saving breakthroughs for pancreatic cancer patients.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.